NanoImaging Services, Inc.

Based in the US, NanoImaging Services, Inc. specializes in cryo-electron microscopy, supporting biopharmaceutical companies in developing innovative therapeutics through advanced structural biology services. NanoImaging Services, Inc. was founded in 2007 in San Diego, US.

The company focuses on cryo-electron microscopy to aid pharmaceutical and biotech companies in novel drug discovery. The founding team includes Bridget Carragher and Clint Potter, with Clint Potter serving as CEO. The company has secured a total of USD 4. 69 mn across multiple funding rounds, with the most recent being a Series B round that raised USD 12.

19 mn on September 4, 2024, reflecting its evolving business strategy in the biopharmaceutical sector. NanoImaging Services specializes in cryo-electron microscopy (cryo-EM) to support pharmaceutical and biotechnology companies in the discovery and development of novel therapeutics. The company's core offerings include high-resolution structural biology services, providing detailed 3D structures of proteins, membrane proteins, and viral particles at resolutions of 3. 5 Å or better.

The company has successfully imaged over 200 AAV samples and 3,700 liposomal samples, including lipid nanoparticles (LNP), extracellular vesicles (EV), and outer membrane vesicles (OMV), catering primarily to clients in the biopharmaceutical industry. NIS operates in global markets across North America, Europe, and Asia, with its services critical for enabling drug discovery, particularly in developing targeted therapies and vaccines. The revenue model for NanoImaging Services is primarily based on B2B transactions, where clients engage the company for specific cryo-EM services tailored to their research and development needs. Clients typically request services through consultation forms, leading to contracts that detail the scope of work, including pricing and timelines.

NIS offers various pricing structures related to project complexity, such as nanoparticle characterization or structural determination, with transactions structured around project deliverables rather than subscription models. This focus ensures steady engagement and revenue generation through specialized services essential for advancing drug development initiatives. In September 2024, NanoImaging Services, Inc. raised USD 12.

2 mn in Series B funding, which will be used to support the development of new cryo-EM products and expand into additional global markets. The company aims to enhance its service offerings and explore opportunities in regions where demand for advanced structural biology solutions is growing, targeting expansion by the end of 2025.